Results 21 to 30 of about 176,444 (236)

Mucinous Bladder Adenocarcinoma: Case Report and Literature Review [PDF]

open access: yesCase Reports in Urology, 2015
Primary mucinous adenocarcinoma is an extremely rare type of bladder cancer, with aggressive behavior and poor response to chemotherapy and radiotherapy. The symptoms are similar to those of other bladder tumors. Surgery is the main treatment and remains
Bruno Mello R. Santos   +3 more
doaj   +2 more sources

Epidemiology of Mucinous Adenocarcinomas [PDF]

open access: yesCancers, 2020
Mucinous (colloid) adenocarcinomas (MAs) are a rare histological subtype of adenocarcinomas where extracellular mucin comprises more than 50% of the tumor. Most literature on MAs relate to cancers from colorectal and breast sites; however, the literature lacks a standardized overview of the MA disease entity. Particularly in colorectal cancer, some MAs
Matthew G. K. Benesch   +1 more
openaire   +2 more sources

Pulmonary Mucinous Adenocarcinoma [PDF]

open access: yes, 2021
Mucinous adenocarcinoma is a rare malignant tumor of the lung, which is accompanied by extremely scarce and nonspecific symptoms. This leads to an increase in the timing of its recognition, especially in young women.
A. P. Petrosian   +5 more
core   +1 more source

Perianal mucinous adenocarcinoma [PDF]

open access: yesCancer, 1977
Perianal mucinous adenocarcinoma, also known as anal duct or anal gland carcinoma, is a rare tumor usually associated with chronic fistulae-in-ano. Whether the tumor occurs primarily and the fistula is a secondary manifestation, or whether this tumor arises in a chronic fistulous tract is debatable. Diagnosis can be made only by open deep biopsy of the
P G, Prioleau, M S, Allen, T, Roberts
openaire   +2 more sources

Confluent cavitated nodules in invasive mucinous adenocarcinoma: A case report [PDF]

open access: yes, 2023
“Invasive mucinous adenocarcinoma is a rare variant of lung adenocarcinoma. Here, we present the case of a patient with invasive mucinous adenocarcinoma with cavitary lung lesions. A 61-year-old painter-and-bricklayer.
López-Hinostroza, Madaleine   +4 more
core   +1 more source

Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Type 3 innate lymphoid cells (ILC3s) are essential for host defense against infection and tissue homeostasis. However, their role in the development of HCC has not been adequately confirmed. In this study, we investigated the immunomodulatory role of short‐chain fatty acids (SCFAs) derived from intestinal microbiota in ILC3
Chupeng Hu   +11 more
wiley   +1 more source

Age-adjusted incidence rates of mucinous adenocarcinoma.

open access: yes, 2023
Age-adjusted incidence rates of mucinous adenocarcinoma.
Yebin Lu (12629756)   +3 more
core   +1 more source

Mucinous Adenocarcinomas of the Vulva

open access: yesGynecologic Oncology, 1995
An 80-year-old nullipara had a 2.0-cm cystic tumor of the right labium majus. Histologic diagnosis was mucinous eccrine carcinoma. Seventy-five percent of these rare skin adnexal tumors arise on the face, eyelid, or scalp; but none has been reported on the vulva.
S A, Ghamande   +4 more
openaire   +2 more sources

Mucinous adenocarcinoma of the renal pelvis [PDF]

open access: yesPostgraduate Medical Journal, 1980
Abstract A case of mucinous adenocarcinoma of the renal pelvis occurring in association with staghorn calculus and severe pyelonephritis is reported. The incidence and aetiopathogenesis of this neoplasm is briefly discussed.
K, Joshi   +3 more
openaire   +2 more sources

The prostatic adenocarcinoma with mucinous features: A review of the literature with three case reports

open access: yes, 2021
Mucinous adenocarcinoma of the prostate is one of the rare variants of the prostatic carcinoma, and its incidence among all prostatic carcinomas is reported to be 0.3% in the literature. If the tumor variant containing extracellular mucin in
Karsiyakali, Nejdet   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy